Essentially identical to the degree of CRC growth inhibition obtained with Cpd14 treatment, Atic KD diminished tumor burden by ~85% in VP mice and by ~65% in Trp53fl/fl mice (Figs. S6f, S6i and S6j). The gene discussed is ATIC; the disease is neoplasm.